Cranbury, N.J.-based Oncobiologics Inc. appointed Joerg Windisch to its board, replacing Yezan Haddadin who resigned.
Windisch, a nominee of Oncobiologics shareholder GMS Tenshi Holdings Pte. Ltd., is COO of Polish biotechnology company Polpharma Biologics. He has worked at Sandoz Biopharmaceuticals for two decades, most recently as chief science officer.
"Joerg is an experienced industry executive and scientist with over 20 years in the development of biological therapeutics. His broad expertise in biosimilar development, manufacturing and regulatory affairs will support our work in further developing our biosimilar product candidate pipeline in the years ahead," Oncobiologics Chairman and CEO Pankaj Mohan said in a statement.
Sandoz Inc. is a Novartis AG unit.